GlaxoSmithKline's Rockville chief lays out priorities for 2018

Favicon The Washington Business Journal

British pharmaceutical giant GlaxoSmithKline PLC said it finally has its full team in place at its new vaccine hub in Rockville, ready to take on some of the region's most well-known biotech competitors with part of its product lineup. This next year, officials said, will be about taking a leadership position in new vaccine technologies and advancing its top priority projects, including its vaccine candidates for shingles as well as respiratory syncytial virus, a common respiratory virus that often...

Read the full article here: The Washington Business Journal

The post: «GlaxoSmithKline's Rockville chief lays out priorities for 2018» has been published on the website The Washington Business Journal where, everyday, you can find the latest news about Washington's area.

Get more articles about this topic

Leave a comment